Development of Superasialoglycoprotein models with combined functions of Liver-cells Recognition and Drugs-inclusion

具有肝细胞识别和药物包涵功能的超级唾液酸糖蛋白模型的开发

基本信息

  • 批准号:
    07558212
  • 负责人:
  • 金额:
    $ 3.58万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1997
  • 项目状态:
    已结题

项目摘要

In drugs and gene delivery, spatio-temporal control of targeting is the most importantsubject by design of cell-recognizable and release-controllable polymeric carriers.In this research project, oligosaccharide-carrying polymers which are capable of recognizing liver cells and incorporating chemicals and DNA reagents are designed and estimated. It was found out that lactose galactose (1, 4-glucose) -carrying polystyrene derivative (PVLA) is one of the best candidates which have higher capacityof hepatocyte-recognition as well as drugs inclusion by in vitro and in vivo assays.Poly-lysine, polysaccharide conjugates polymers were also synthesized and characterised as hepatocyte-specific DNA carrier to heptoma cell (HepG2).Copolymers consisiting of poly-L-lysine backbone and hyaluronic acid side chain were also prepared and evaluated in viewpoint at sinusoidal endothelial cell tergeting as DNA carriers.
在药物和基因传递中,靶向的时空控制是最重要的课题,通过设计细胞可识别和释放可控的聚合物载体,本研究设计并评价了能够识别肝细胞并结合化学物质和DNA试剂的寡糖载体聚合物。发现乳糖半乳糖载1,4-葡萄糖的聚苯乙烯衍生物(PVLA)是一种具有较高的肝细胞识别能力和体内外药物包合能力的药物载体。还合成了多糖缀合物聚合物,并将其表征为肝癌细胞(HepG 2)的肝细胞特异性DNA载体。制备了赖氨酸主链和透明质酸侧链,并对它们作为DNA载体的应用前景进行了评价。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
C.S.Cho, Y.I.Jeong, T.Ishihara, R.Takei, J.U.Park, K.H.Park, A.Maruyama, T.Akaike: "Simple preparation of nanoporticles coated with carbohydrate-carrying polymers" Biomaterials.18. 323-326 (1997)
C.S.Cho、Y.I.Jeong、T.Ishihara、R.Takei、J.U.Park、K.H.Park、A.Maruyama、T.Akaike:“简单制备涂有碳水化合物携带聚合物的纳米颗粒”Biomaterials.18。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Jeong-Ung Park: "Preparation of dendric graft copolymer consisting of poly (L-lysine) and arabinogalactan as a hepatocyte specific DNA carrier" Preparative Biochemistry & Biotechnology. in press.
Jeong-Ung Park:“制备由聚(L-赖氨酸)和阿拉伯半乳聚糖组成的树状接枝共聚物作为肝细胞特异性 DNA 载体”制备生物化学
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shoichiro ASAYAMA,Masayuki NOGAWA,Yoshiyuki TAKEI,Toshihiro AKAIKE,and Atushi MARUYAMA: "Synthesis of Novel Polyampholyte Comb-Type Copolymers Consisiting of a Poly (L-lysine) Backbone and Hyaluronic Acid Side Chains for a DNA Carrier" Bioconjugate Chem.
Shoichiro ASAYAMA、Masayuki NOGAWA、Yoshiyuki TAKEI、Toshihiro AKAIKE 和 Atushi MARUYAMA:“由聚(L-赖氨酸)主链和用于 DNA 载体的透明质酸侧链组成的新型聚两性电解质梳型共聚物的合成”Bioconjugate Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.-H.Park, R.Takei, M.Goto, A.Maruyama, A.Kobayashi, K.Kobayashi, T.Akaike.: "Specific interaction between erythrocyte and glucose carrying polymermediated by type-1 glucose transporter (GLUT-1) on cell membrane" J.Biochemistry. 121. 997-1001 (1997)
K.-H.Park、R.Takei、M.Goto、A.Maruyama、A.Kobayashi、K.Kobayashi、T.Akaike.:“红细胞和携带葡萄糖的聚合物之间由 1 型葡萄糖转运蛋白 (GLUT-
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
丸山厚、赤池敏宏: "医用高分子材料-Biomedecal Polymers-" 有機合成化学協会誌. 55(5). 427-435 (1997)
Atsushi Maruyama、Toshihiro Akaike:“医用高分子材料 - 生物医学聚合物”有机合成化学学会杂志 55(5) (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AKAIKE Toshihiro其他文献

AKAIKE Toshihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AKAIKE Toshihiro', 18)}}的其他基金

Regulation of functions and differentiation of ES/iPS cells by designing cell-recognizable chimera matrices
通过设计细胞可识别的嵌合体基质来调节 ES/iPS 细胞的功能和分化
  • 批准号:
    23220014
  • 财政年份:
    2011
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Regulation of Stem Cells Gene Expression using Apatite nanocarriers coated with Cell-reconizable chimeric Protein.
使用涂有细胞可识别嵌合蛋白的磷灰石纳米载体调节干细胞基因表达。
  • 批准号:
    19200038
  • 财政年份:
    2007
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Design of Cell-Recognizable Nano-device and Application to Biosensing and Tissue-engineering
细胞识别纳米器件的设计及其在生物传感和组织工程中的应用
  • 批准号:
    15100008
  • 财政年份:
    2003
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Molecular Synchronization for Design of New Materials System
新材料体系设计的分子同步化
  • 批准号:
    10186101
  • 财政年份:
    1998
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Design of Polymeric Supramolecular-assembly for Targeted Therapy of Liver
用于肝脏靶向治疗的聚合物超分子组装体的设计
  • 批准号:
    09308035
  • 财政年份:
    1997
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
DESIGN OF CELL SPECIFIC CARRIERS FOR GENES AND PEPTIDES
基因和肽的细胞特异性载体的设计
  • 批准号:
    08044128
  • 财政年份:
    1996
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
DEVELOPMENT OF SUPER-BIOARTIFICIAL LIVER BASED ON THE HEPATOCYTE-SPECIFIC POLYMER DESIGN AND GENETIC ENGINEERING
基于肝细胞特异性聚合物设计和基因工程的超级生物人工肝的开发
  • 批准号:
    06403035
  • 财政年份:
    1994
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Application of biodegradable Nanoparticles coated with sugar-carrying polymer to targetted drug delivery
含糖聚合物包覆的可生物降解纳米粒子在靶向药物递送中的应用
  • 批准号:
    05558108
  • 财政年份:
    1993
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
Defining the role of G6pc-high hepatocyte and Slc25a44 in metabolism via spatial transcriptome
通过空间转录组定义 G6pc-high 肝细胞和 Slc25a44 在代谢中的作用
  • 批准号:
    22KK0271
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease
原代肝细胞和工程 iPSC 衍生的肝细胞样细胞移植治疗 α-1 抗胰蛋白酶缺乏相关的肝病
  • 批准号:
    10607039
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
Development of a Microphysiological System for Transvascular Drug Delivery to 3D Hepatocyte Spheroids
开发用于 3D 肝细胞球体经血管药物输送的微生理系统
  • 批准号:
    23K19214
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH
确定 Ube4A 调节 NAFLD/NASH 的肝细胞特异性机制
  • 批准号:
    10587876
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
Integrative analysis of metabolomics, transcriptomics and proteomics to study mechanisms that regulate lentiviral vector hepatocyte transduction
代谢组学、转录组学和蛋白质组学的综合分析,研究慢病毒载体肝细胞转导的调节机制
  • 批准号:
    2891574
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Studentship
Integrative analysis of metabolomics transcriptomics and proteomics to study mechanisms that regulate lentiviral vector hepatocyte transduction
代谢组学、转录组学和蛋白质组学的综合分析,研究调节慢病毒载体肝细胞转导的机制
  • 批准号:
    BB/Y513532/1
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Training Grant
Characterizing zonated hepatocyte sexual dimorphism and its role in fatty liver disease
分区肝细胞性别二态性的特征及其在脂肪肝疾病中的作用
  • 批准号:
    10588098
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
Roles of the Lysine Methyl Transferase (KMT) 2D in hepatocyte cell identity and hepatocellular carcinoma (HCC) progression
赖氨酸甲基转移酶 (KMT) 2D 在肝细胞细胞识别和肝细胞癌 (HCC) 进展中的作用
  • 批准号:
    472010
  • 财政年份:
    2022
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Fellowship Programs
The role of hepatocyte tPA in hepatic VLDL production.
肝细胞 tPA 在肝 VLDL 产生中的作用。
  • 批准号:
    10420269
  • 财政年份:
    2022
  • 资助金额:
    $ 3.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了